The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership governance consists of an Executive Committee and three active working groups. The three working groups identify and develop criteria, goals, and objectives and review progress and milestones. The working groups are managed by the Foundation for the National Institutes of Health (FNIH) and report to the ACTIV Executive Committee. An ACTIV Partnership Leadership Group, which includes representatives from all the ACTIV partners as well as the Executive Committee members, also reviews the progress of the ACTIV partnership regularly.



  • Biomedical Advanced Research and Development Authority
  • Centers for Disease Control and Prevention
  • Department of Defense
  • Department of Veterans Affairs
  • European Medicines Agency
  • National Institutes of Health┬á
  • Operation Warp Speed
  • U.S. Food and Drug Administration


  • Bill & Melinda Gates Foundation
  • Fred Hutchinson Cancer Research Center
  • Foundation for the National Institutes of Health
  • RTI International


  • AbbVie
  • Amgen
  • AstraZeneca
  • Bristol Myers Squibb
  • Dewpoint Tx
  • Eisai
  • Eli Lilly and Company
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Moderna
  • Novartis
  • Novavax
  • Pfizer
  • Roche-Genentech
  • Rhythm Therapeutics
  • Sanofi
  • Takeda
  • Vir Biotechnology